NY State Senate Bill 2017-S5357A

Archive: Last Bill Status - In Senate Committee Health Committee

Introduced
- In Committee Assembly
- In Committee Senate
- On Floor Calendar Assembly
- On Floor Calendar Senate
- Passed Assembly
- Passed Senate
Delivered to Governor
Signed By Governor

Please enter your contact information

First Name

Last Name

Email Address

A valid email address is required.

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

View Actions

	Assembly Actions - Lowercase Senate Actions - UPPERCASE
Jan 03, 2018	referred to health
Jun 21, 2017	committed to rules
Jun 19, 2017	amended on third reading 5357a
Jun 19, 2017	vote reconsidered - restored to third reading returned to senate recalled from assembly
Jun 13, 2017	referred to health delivered to assembly passed senate
Jun 05, 2017	advanced to third reading
May 24, 2017	2nd report cal.
May 23, 2017	1st report cal.1147
Mar 22, 2017	referred to health

Votes

- Jun 13, 2017 - Floor Vote
  S5357A
  
  63
  
  Aye
  
  0
  
  Nay
  
  0
  
  Absent
  
  0
  
  Excused
  
  0
  
  Abstained
  - - Floor Vote: Jun 13, 2017
      
      aye (63)
      
      Addabbo Jr.
      
      Akshar
      
      Alcantara
      
      Amedore
      
      Avella
      
      Bailey
      
      Benjamin
      
      Bonacic
      
      Boyle
      
      Breslin
      
      Brooks
      
      Carlucci
      
      Comrie
      
      Croci
      
      DeFrancisco
      
      Diaz
      
      Dilan
      
      Felder
      
      Flanagan
      
      Funke
      
      Gallivan
      
      Gianaris
      
      Golden
      
      Griffo
      
      Hamilton
      
      Hannon
      
      Helming
      
      Hoylman-Sigal
      
      Jacobs
      
      Kaminsky
      
      Kennedy
      
      Klein
      
      Krueger
      
      LaValle
      
      Lanza
      
      Larkin
      
      Latimer
      
      Little
      
      Marcellino
      
      Marchione
      
      Montgomery
      
      Murphy
      
      O'Mara
      
      Ortt
      
      Parker
      
      Peralta
      
      Persaud
      
      Phillips
      
      Ranzenhofer
      
      Ritchie
      
      Rivera
      
      Robach
      
      Sanders Jr.
      
      Savino
      
      Serino
      
      Serrano
      
      Seward
      
      Squadron
      
      Stavisky
      
      Stewart-Cousins
      
      Tedisco
      
      Valesky
      
      Young
  May 23, 2017 - Health Committee Vote
  S5357A
  
  17
  
  Aye
  
  0
  
  Nay
  
  0
  
  Aye with Reservations
  
  0
  
  Absent
  
  0
  
  Excused
  
  0
  
  Abstained
  - - Health Committee Vote: May 23, 2017
      
      aye (17)
      
      Felder
      
      Golden
      
      Hannon
      
      Hoylman-Sigal
      
      Jacobs
      
      Kaminsky
      
      Larkin
      
      Little
      
      Montgomery
      
      Murphy
      
      Persaud
      
      Ritchie
      
      Rivera
      
      Seward
      
      Stavisky
      
      Tedisco
      
      Valesky

Bill Amendments

Original

A (Active)

co-Sponsors

View additional co-sponsors

2017-S5357 - Details

Current Committee:: Senate Health
Law Section:: Public Health Law
Laws Affected:: Amd §3306, Pub Health L

2017-S5357 - Summary

Provides for the express addition and addition by reference of numerous controlled substances to the state schedules of controlled substances.

2017-S5357 - Sponsor Memo

                                 BILL NUMBER:  S5357

 TITLE OF BILL :  An act to amend the public health law, in relation
to adding substances to the schedules of controlled substances

 PURPOSE :

This bill would update the State controlled substances schedules,
promoting consistency with the federal schedules and promoting health
and safety.

 SUMMARY OF PROVISIONS :

Section 1 of the bill would add a synthetic opioid analgesic; often
known as AH-7921, and seven fentantyl analogs to Schedule I(b) of
Public Health Law (PHL) § 3306. The section would also add any
controlled substance listed in 21 U.S.C. § 812, Schedule I(a), that is
not otherwise listed in state Schedule 1(b) to such schedule.

Section 2 of the bill would amend PHL § 3306, Schedule I(c) to add the
controlled substances listed in 21 U.S.C. § 812, Schedule I(b), if not
already listed therein.

Section 3 of the bill would amend PHL § 3306, Schedule I(d) to correct
the spelling of ibogane.

Section 4 of the bill would add a number of substances to PHL § 3306,
Schedule I(d). Additionally, the section would add the controlled
substances listed in 21 U.S.C. § 812, Schedule I(c) or (d), if not
already listed therein.

Section 5 of the bill would amend PHL § 3306, Schedule I(e), to add
the controlled substances listed in 21 U.S.C. § 812, Schedule III(b)
or IV, if not already listed therein.

Section 6 would amend PHL § 3306, Schedule II(c), to add the
controlled substances listed in 21 U.S.C. § 812, Schedule II, Schedule
III(d) or Schedule V, if not already listed therein.

Section 7 would amend PHL § 3306, Schedule II(d) to add the controlled
substances listed in 21 U.S.C. § 812, Schedule III(a), if not already
listed therein.

Section 8 of the bill would amend PHL § 3306, Schedule II (h) to add
methasterone and prostanozol.

Section 9 of the bill would amend PHL § 3306, Schedule III (c) to add
perampanel.

Section 10 of the bill would amend PHL § 3306, Schedule IV (c) to add
alfaxalone and suvorexant.

Section 11 of the bill would amend PHL § 3306, Schedule IV(f) to
clarify that the inclusion of salts and isomers applies whenever such
salts or isomers are possible within the specific chemical designation
of a substance. The section also would add lorcaserin and eluxadoline
to Schedule IV(f).

Section 12 of the bill would amend PHL § 3306, Schedule V(d) to add
brivaracetam.

Section 13 would set forth the effective date.

 JUSTIFICATION :


This bill would update the New York State controlled substances
schedules to conform to the current federal schedules of controlled
substances. Individuals often exploit the fact that certain drugs
classified as controlled substances under federal law are not
similarly classified as controlled substances under New York law, and
thus are more easily diverted. Consistency between the State and
federal schedules is therefore important to address the prevalence of
abuse and misuse of controlled substances. At the same time, the State
should not wait for final federal action when it appears that a
substance is dangerous and should be scheduled.

The bill would further add several fentantyl analogs, including some
which are temporarily listed in the federal schedule. This is
consistent with a recommendation made by the Heroin and Opioid Task
Force, convened by the Governor to identify ways to address the
ongoing crisis of heroin and opioid addiction. In making this
recommendation, the Task Force noted that fentanyl is more potent than
heroin but has been found mixed with and sold as heroin, which can be
particularly dangerous. Adding these precursors to the schedule also
would eliminate a loophole which otherwise might allow drug dealers to
escape prosecution.

The bill would also add other known dangerous substances to the State
schedule of controlled substances, including a synthetic opioid
analgesic, often is known as AH-7921, which can cause a psychoactive
reaction and has led to a number of deaths within the United States
and other counties. Finally, the bill would clarify that the inclusion
of salts and isomers applies whenever such salts or isomers are
possible within the specific chemical designation of a substance.

 LEGISLATIVE HISTORY :

New bill.

 FISCAL IMPLICATIONS :

None.

 EFFECTIVE DATE :
90 days, succeeding enactment.

2017-S5357 - Bill Text download pdf

                            
 
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   5357
 
                        2017-2018 Regular Sessions
 
                             I N  S E N A T E
 
                              March 22, 2017
                                ___________
 
 Introduced by Sen. HANNON -- (at request of the Department of Health) --
   read  twice  and  ordered printed, and when printed to be committed to
   the Committee on Health
 
 AN ACT to amend the public health law, in relation to adding  substances
   to the schedules of controlled substances

   THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section 1. Subdivision (b) of schedule I of section 3306 of the public
 health law is amended by adding nine new paragraphs 56, 57, 58, 59,  60,
 61, 62, 63 and 64 to read as follows:
   (56) 3,4-DICHLORO-N-{(1-DIMETHYLAMINO)CYCLOHEXYLMETHYL}BENZAMIDE. SOME
 TRADE OR OTHER NAMES: AH-7921.
   (57) N-(1-PHENETHYLPIPERIDIN-4-YL)-N-PHENLYACETAMIDE   (ACETYL  FENTA-
 NYL).
   (58) -(1-PHENETHYLPIPERIDIN-4-YL)-N-PHENYLBUTYRAMIDE  (BUTYRYL  FENTA-
 NYL).
   (59) N-{1-{2-HYDROXY-2-(THIOPHEN-2-YL)ETHYL}PIPERIDIN-4-YL}- N-PHENYL-
 PROPIONAMIDE (BETA-HYDROXYTHIOFENTANYL).
   (60) N-(1-PHENETHYLPIPERDIN-4-YL)-N-PHENYLFURAN-2-CARBOXAMIDE (FURANYL
 FENTANYL).
   (61) N-PHENYL-N-{1-(2-PHENYLETHYL)-4-PIPERIDINYL}-PENTANAMIDE (VALERYL
 FENTANYL, PENTANOYL FENTANYL, PENTANYL FENTANYL).
   (62) U-47700(3,4-DICHLORO-N-(2-(DIMETHYLAMINO)CYCLOHEXYL)-N-METHYL-BEN-
 ZAMIDE)YL.
   (63) 4-CHLORO-N-{1-{2-(4-NITROPHENYL)ETHYL}-2-PIPERIDINYLIDENE}-BENZENE-
 SULFONAMIDE (W18).
   (64)  ANY  CONTROLLED  SUBSTANCE  LISTED  IN 21 U.S.C. § 812, SCHEDULE
 I(A), THAT IS NOT OTHERWISE LISTED IN THIS SCHEDULE.
   § 2. Subdivision (c) of schedule I  of  section  3306  of  the  public
 health law, is amended by adding a new paragraph 24 to read as follows:
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD10140-01-7

 S. 5357                             2
 
   (24)  ANY  CONTROLLED  SUBSTANCE  LISTED  IN 21 U.S.C. § 812, SCHEDULE
 I(B), THAT IS NOT OTHERWISE LISTED IN THIS SCHEDULE.
   §  3. Paragraph 11 of subdivision (d) of schedule I of section 3306 of
 the public health law, as added by chapter 664 of the laws of  1985,  is
 amended to read as follows:
   (11) [Ibogane]  IBOGAINE Some trade and other names: 7-ethyl-6, 6&, 7,
 8, 9, 10, 12, 13-octahydro-2-methoxy-6, 9-methano-5h-pyrido  {1',2':1,2}
 azepino {5,4-b} indole: tabernanthe iboga.
   §  4.  Subdivision  (d)  of  schedule  I of section 3306 of the public
 health law is amended by adding twenty-one new paragraphs  36,  37,  38,
 39,  40,  41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55 and
 56 to read as follows:
   (36) 5-METHOXY-N,N-DIMETHYLTRYPTAMINE.
   (37) ALPHA-METHYLTRYPTAMINE. SOME TRADE OR OTHER NAMES: AMT.
   (38) 5-METHOXY-N,N-DIISOPROPYLTRYPTAMINE. SOME TRADE OR  OTHER  NAMES:
 5-MEO-DIPT.
   (39) 5-(1,1-DIMETHYLHEPTYL)-2-{(1R,3S)-3-HYDROXYCYCLOHEXYL}-PHENOL.
 SOME TRADE OR OTHER NAMES: CP-47,497.
   (40)     5-(1,1-DIMETHYLOCTYL)-2-{(1R,3S)-3-HYDROXYCYCLOHEXYL}-PHENOL.
 SOME TRADE OR OTHER NAMES: CANNABICYCLOHEXANOL OR CP-47,497 C8-HOMOLOG.
   (41)  1-BUTYL-3-(1-NAPHTHOYL)INDOLE.  SOME  TRADE  OR   OTHER   NAMES:
 JWH-073.
   (42)   1-HEXYL-3-(1-NAPHTHOYL)INDOLE.   SOME  TRADE  OR  OTHER  NAMES:
 JWH-019.
   (43) 1-{2-(4-MORPHOLINYL)ETHYL}-3-(1-NAPHTHOYL)INDOLE. SOME  TRADE  OR
 OTHER NAMES: JWH-200.
   (44)  1-PENTYL-3-(2-METHOXYPHENYLACETYL)INDOLE.  SOME  TRADE  OR OTHER
 NAMES: JWH-250.
   (45) 1-PENTYL-3-{1-(4-METHOXYNAPHTHOYL)}INDOLE. SOME  TRADE  OR  OTHER
 NAMES: JWH-081.
   (46)  1-PENTYL-3-(4-METHYL-1-NAPHTHOYL)INDOLE.  SOME  TRADE  OR  OTHER
 NAMES:  JWH-122.
   (47)  1-PENTYL-3-(4-CHLORO-1-NAPHTHOYL)INDOLE.  SOME  TRADE  OR  OTHER
 NAMES:  JWH-398.
   (48)  1-(5-FLUOROPENTYL)-3-(1-NAPHTHOYL)INDOLE.  SOME  TRADE  OR OTHER
 NAMES: AM2201.
   (49) 1-(5-FLUOROPENTYL)-3-(2-IODOBENZOYL)INDOLE. SOME TRADE  OR  OTHER
 NAMES: AM694.
   (50)   1-PENTYL-3-{(4-METHOXY)-BENZOYL}INDOLE.  SOME  TRADE  OR  OTHER
 NAMES: SR-19 AND RCS-4.
   (51) 1-CYCLOHEXYLETHYL-3-(2-METHOXYPHENYLACETYL)INDOLE. SOME TRADE  OR
 OTHER NAMES: SR-18 AND RCS-8.
   (52)  1-PENTYL-3-(2-CHLOROPHENYLACETYL)INDOLE.  SOME  TRADE  OR  OTHER
 NAMES:  JWH-203.
   (53)  (1-PENTYL-1H-INDOL-3-YL)(2,2,3,3-TETRAMETHYLCYCLOPROPYL)  METHA-
 NONE. SOME TRADE OR OTHER NAMES: UR-144.
   (54)
 {1-(5-FLUORO-PENTYL)-1H-INDOL-3-YL}(2,2,3,3-TETRAMETHYLCYCLOPROPYL)
 METHANONE. SOME TRADE OR OTHER NAMES: 5-FLUORO-UR-144,XLR11.
   (55) N-(1-ADAMANTYL)-1-PENTLY-1H-INDAZOLE-3-CARBOXAMIDE. SOME TRADE OR
 OTHER NAMES: APINACA, AKB 48.
   (56)  ANY  CONTROLLED  SUBSTANCE  LISTED IN 21 U.S.C. § 812, SCHEDULES
 I(C) OR I(D), THAT IS NOT OTHERWISE LISTED IN THIS SCHEDULE.
   § 5. Subdivision (e) of schedule I  of  section  3306  of  the  public
 health law is amended by adding a new paragraph 25 to read as follows:

 S. 5357                             3
 
   (25)  ANY  CONTROLLED  SUBSTANCE  LISTED IN 21 U.S.C. § 812, SCHEDULES
 III(B) OR IV, THAT IS NOT OTHERWISE LISTED IN THIS SECTION.
   §  6.  Subdivision  (c)  of  schedule II of section 3306 of the public
 health law is amended by adding a new paragraph 29 to read as follows:
   (29) ANY CONTROLLED SUBSTANCE LISTED IN 21 U.S.C. § 812 SCHEDULES  II,
 III(D) OR V, THAT IS NOT OTHERWISE LISTED IN THIS SECTION.
   §  7.  Subdivision  (d)  of  schedule II of section 3306 of the public
 health law is amended by adding a new paragraph 6 to read as follows:
   (6) ANY CONTROLLED SUBSTANCE LISTED  IN  21  U.S.C.  §  812,  SCHEDULE
 III(A), THAT IS NOT OTHERWISE LISTED IN THIS SECTION.
   §  8.  Subdivision  (h)  of  schedule II of section 3306 of the public
 health law is amended by adding two new paragraphs 64 and 65 to read  as
 follows:
   (64) METHASTERONE (2{ALPHA}17{ALPHA}-DIMETHYL-5{ALPHA}-ANDROSTAN-
 17{BETA}-OL-3-ONE).
   (65) PROSTANOZOL (17{BETA}-HYDROXY-5{ALPHA}-ANDROSTANO{3,2-C}PYRAZOLE).
   §  9.  Subdivision  (c)  of schedule III of section 3306 of the public
 health law, is amended by adding a new paragraph 15 to read as follows:
   (15) PERAMPANEL.
   § 10. Subdivision (c) of schedule IV of section  3306  of  the  public
 health  law is amended by adding two new paragraphs 54 and 55 to read as
 follows:
   (54) ALFAXALONE.
   (55) SUVOREXANT.
   § 11. Subdivision (f) of schedule IV of section  3306  of  the  public
 health  law, as added by chapter 664 of the laws of 1985, paragraph 2 as
 added by chapter 457 of the laws of 2006 and paragraph  3  as  added  by
 section  14  of part C of chapter 447 of the laws of 2012, is amended to
 read as follows:
   (f) Other substances. Unless specifically excepted or unless listed in
 another schedule, any material, compound, mixture or  preparation  which
 contains  any quantity of the following substances, including its salts,
 ISOMERS, AND SALTS, OF SUCH ISOMERS,  WHENEVER  THE  EXISTENCE  OF  SUCH
 SALTS, ISOMERS, AND SALTS OF ISOMERS IS POSSIBLE:
   (1) Pentazocine.
   (2) Butorphanol (including its optical isomers).
   (3) Tramadol in any quantities.
   (4) LORCASERIN.
   (5) ELUXADOLINE.
   §  12.  Subdivision  (d)  of  schedule V of section 3306 of the public
 health law is amended by adding a new paragraph 4 to read as follows:
   (4) BRIVARACETAM.
   § 13. This act shall take effect on the ninetieth day after  it  shall
 have become a law.

co-Sponsors

View additional co-sponsors

2017-S5357A (ACTIVE) - Details

Current Committee:: Senate Health
Law Section:: Public Health Law
Laws Affected:: Amd §3306, Pub Health L

2017-S5357A (ACTIVE) - Summary

Provides for the express addition and addition by reference of numerous controlled substances to the state schedules of controlled substances.

2017-S5357A (ACTIVE) - Sponsor Memo

                                 BILL NUMBER:  S5357A

 TITLE OF BILL :  An act to amend the public health law, in relation
to adding substances to the schedules of controlled substances

 PURPOSE :

The purpose of this bill is to update the State controlled substances
schedules, promoting consistency with the federal schedules, and
promoting health and safety.

 SUMMARY OF PROVISIONS :

Section 1 of the bill adds a synthetic opioid analgesic, often known
as AH-7921, and one fentanyl analog, Acetyl Fentanyl, to Schedule I(b)
of Public Health Law (PHL) § 3306, to conform with the federal
schedule.

Section 2 of the bill would amend Schedule 1(d) of PHL§ 3306 to
correct the spelling of ibogaine and to add a technical correction.

Section 3 of the bill would add several substances to Schedule 1(d) of
PHL§ 3306, to conform with the federal schedule.

Section 4 of the bill would add the substance thiafentanil to Schedule
I1(c) of PHL§ 3306, to conform with the federal schedule.

Section 5 of the bill would add methasterone and prostanozol to
Schedule II(h) of PHL§ 3306, to conform with the federal schedule.

Section 6 of the bill would add perampanel to Schedule III(c) of PHL§
3306, to conform to the federal schedule.

Section 7 of the bill would add alfaxalone and suvorexant to Schedule
IV(c) of PHL§ 3306, to conform with the federal schedule.

Section 8 of the bill would amend the opening paragraph of Schedule
IV(f) to clarify the inclusion of salts and isomers. The section also
would add lorcaserin and eluxadoline to the schedule, to conform to
the federal schedule.

Section 9 of the bill would add brivaracetam to Schedule V(d) of PHL§
3306.

Section 10 sets forth the effective date.

 JUSTIFICATION :

Drug-seeking individuals often exploit the fact that certain drugs
classified as controlled substances under federal law are not
controlled substances under New York law and are more easily diverted.
Consistency between the New York State and federal schedule is
therefore important to address the prevalence of abuse and misuse of
controlled substances.

This bill would add a fentanyl analog, consistent with a
recommendation made by the Heroin and Opioid Task Force, convened by
the Governor to identify ways to address the ongoing crisis of heroin
and opioid addiction. In making this recommendation, the Task Force
noted that fentanyl is more potent than heroin but has been found
mixed with and sold as heroin, which can be particularly dangerous.

The bill also adds other known dangerous substances to the schedule of
controlled substances, including a synthetic opioid analgesic, often
is known as AH-7921, which can cause a psychoactive reaction and has
led to a number of deaths within the United States and other counties;
methasterone and prostanozol, both considered to be "designer
steroids;" perampanel, a drug which can be effective in blocking
seizures but may have strong hallucinogenic and depressant effects and
other drugs which have abuse potential which are already scheduled by
the federal government.

Finally, the bill clarifies that the inclusion of salts and isomers
applies within the specific chemical designation of a substance.

 LEGISLATIVE HISTORY :

New bill

 FISCAL IMPLICATIONS :

None.

 EFFECTIVE DATE :
90 days, succeeding enactment.

2017-S5357A (ACTIVE) - Bill Text download pdf

                            
 
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                  5357--A
     Cal. No. 1147
 
                        2017-2018 Regular Sessions
 
                             I N  S E N A T E
 
                              March 22, 2017
                                ___________
 
 Introduced  by  Sens. HANNON, GALLIVAN, HELMING, LARKIN, MURPHY, O'MARA,
   RANZENHOFER, RITCHIE -- (at request of the Department  of  Health)  --
   read  twice  and  ordered printed, and when printed to be committed to
   the Committee on Health -- reported  favorably  from  said  committee,
   ordered to first and second report, ordered to a third reading, passed
   by  Senate and delivered to the Assembly, recalled, vote reconsidered,
   restored to third reading, amended and  ordered  reprinted,  retaining
   its place in the order of third reading
 
 AN  ACT to amend the public health law, in relation to adding substances
   to the schedules of controlled substances
 
   THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section 1. Subdivision (b) of schedule I of section 3306 of the public
 health  law is amended by adding two new paragraphs 56 and 57 to read as
 follows:
   (56) 3,4-DICHLORO-N-{(1-DIMETHYLAMINO)CYCLOHEXYLMETHYL}BENZAMIDE. SOME
 TRADE OR OTHER NAMES: AH-7921.
   (57)  N-(1-PHENETHYLPIPERIDIN-4-YL)-N-PHENYLDECTAMIDE  (ACETYL  FENTA-
 NYL).
   §  2. Paragraph 11 of subdivision (d) of schedule I of section 3306 of
 the public health law, as added by chapter 664 of the laws of  1985,  is
 amended to read as follows:
   (11)  [Ibogane] IBOGAINE Some trade and other names: 7-ethyl-6, 6&, 7,
 8, 9, 10, 12, 13-octahydro-2-methoxy-6,  [9-methano-5h-pyrido]  9-METHA-
 NO-5H-PYRIDO {1',2':1,2} azepino {5,4-b} indole: tabernanthe iboga.
   §  3.  Subdivision  (d)  of  schedule  I of section 3306 of the public
 health law is amended by adding thirty-five new paragraphs 36,  37,  38,
 39,  40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56,
 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, and 70  to  read  as
 follows:
   (36) 5-METHOXY-N,N-DIMETHYLTRYPTAMINE.

  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets

                       [ ] is old law to be omitted.
                                                            LBD10140-09-7

 S. 5357--A                          2
 
   (37) ALPHA-METHYLTRYPTAMINE. SOME TRADE OR OTHER NAMES: AMT.
   (38) 5-METHOXY-N,N-DIISOPROPYLTRYPTAMINE.  SOME  TRADE OR OTHER NAMES:
 5-MEO-DIPT.
   (39) 5-(1,1-DIMETHYLHEPTYL)-2-{(1R,3S)-3-HYDROXYCYCLOHEXYL}-PHENOL.
 SOME TRADE OR OTHER NAMES: CP-47,497.
   (40) 5-(1,1-DIMETHYLOCTYL)-2-{(1R,3S)-3-HYDROXYCYCLOHEXYL}-PHENOL.
 SOME TRADE OR OTHER NAMES: CANNABICYCLOHEXANOL OR CP-47,497 C8-HOMOLOG.
   (41) 1-BUTYL-3-(1-NAPHTHOYL)INDOLE.  SOME  TRADE   OR   OTHER   NAMES:
 JWH-073.
   (42) 1-HEXYL-3-(1-NAPHTHOYL)INDOLE.   SOME   TRADE   OR  OTHER  NAMES:
 JWH-019.
   (43) 1-{2-(4-MORPHOLINYL)ETHYL}-3-(1-NAPHTHOYL)INDOLE. SOME  TRADE  OR
 OTHER NAMES: JWH-200.
   (44) 1-PENTYL-3-(2-METHOXYPHENYLACETYL)INDOLE.  SOME  TRADE  OR  OTHER
 NAMES: JWH-250.
   (45) 1-PENTYL-3-{1-(4-METHOXYNAPHTHOYL)}INDOLE. SOME  TRADE  OR  OTHER
 NAMES: JWH-081.
   (46) 1-PENTYL-3-(4-METHYL-1-NAPHTHOYL)INDOLE.   SOME  TRADE  OR  OTHER
 NAMES:  JWH-122.
   (47) 1-PENTYL-3-(4-CHLORO-1-NAPHTHOYL)INDOLE.  SOME  TRADE  OR   OTHER
 NAMES:  JWH-398.
   (48) 1-(5-FLUOROPENTYL)-3-(1-NAPHTHOYL)INDOLE.  SOME  TRADE  OR  OTHER
 NAMES: AM2201.
   (49) 1-(5-FLUOROPENTYL)-3-(2-IODOBENZOYL)INDOLE. SOME TRADE  OR  OTHER
 NAMES: AM694.
   (50) 1-PENTYL-3-{(4-METHOXY)-BENZOYL}INDOLE.   SOME   TRADE  OR  OTHER
 NAMES: SR-19 AND RCS-4.
   (51) 1-CYCLOHEXYLETHYL-3-(2-METHOXYPHENYLACETYL)INDOLE. SOME TRADE  OR
 OTHER NAMES: SR-18 AND RCS-8.
   (52) 1-PENTYL-3-(2-CHLOROPHENYLACETYL)INDOLE.   SOME  TRADE  OR  OTHER
 NAMES:  JWH-203.
   (53) (1-PENTYL-1H-INDOL-3-YL)(2,2,3,3-TETRAMETHYLCYCLOPROPYL)   METHA-
 NONE. SOME TRADE OR OTHER NAMES: UR-144.
   (54) {1-(5-FLUORO-PENTYL)-1H-INDOL-3-YL}(2,2,3,3-TETRAMETHYLCYCLOPROPYL)
 METHANONE. SOME TRADE OR OTHER NAMES: 5-FLUORO-UR-144,XLR11.
   (55) N-(1-ADAMANTYL)-1-PENTYL-1H-INDAZOLE-3-CARBOXAMIDE. SOME TRADE OR
 OTHER NAMES: APINACA, AKB 48.
   (56) QUINOLIN-8-YL  1-PENTYL-1H-INDOLE-3-CARBOXYLATE.  SOME  TRADE  OR
 OTHER NAMES: PB-22 AND QUPIC.
   (57) QUINOLIN-8-YL 1-(5-FLUOROPENTYL)-1H-INDOLE-3-CARBOXYLATE.    SOME
 TRADE OR OTHER NAMES: 5-FLUORO-PB-22 AND 5F-PB-22.
   (58) N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-(4-FLUOROBENZYL)- 1H-INDA-
 ZOLE-3-CARBOXAMIDE. SOME TRADE OR OTHER NAMES: AB-FUBINACA.
   (59) N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1-PENTYL-1H-
 INDAZOLE-3-CARBOXAMIDE. SOME TRADE OR OTHER NAMES: ADB-PINACA.
   (60) 4-METHYL-N-ETHYLCATHINONE. SOME TRADE OR OTHER NAMES:  4-MEC.
   (61) 4-METHYL-ALPHA-PYRROLIDINOPROPIOPHENONE.   SOME  TRADE  OR  OTHER
 NAMES: 4-MEPPP.
   (62) ALPHA-PYRROLIDINOPENTIOPHENONE. SOME TRADE OR OTHER NAMES: 2-PVP.
   (63) 1-(1,3-BENZODIOXOL-5-YL)-2-(METHYLAMINO)BUTAN-1-ONE.  SOME  TRADE
 OR OTHER NAMES: BUTYLONE AND BK-MBDB.
   (64) 2-(METHYLAMINO)-1-PHENYLPENTAN-1-ONE.  SOME TRADE OR OTHER NAMES:
 PENTEDRONE.
   (65) 1-(1,3-BENZODIOXOL-5-YL)-2-(METHYLAMINO)PENTAN-1-ONE.  SOME TRADE
 OR OTHER NAMES: PENTYLONE AND BK-MBDP.

 S. 5357--A                          3
 
   (66) 4-FLUORO-N-METHYLCATHINONE. SOME TRADE OR OTHER NAMES:  4-FMC AND
 FLEPHEDRONE.
   (67) 3-FLUORO-N-METHYLCATHINONE. SOME TRADE OR OTHER NAMES:  3-FMC.
   (68) 1-(NAPHTHALEN-2-YL)-2-(PYRROLIDIN-1-YL)PENTAN-1-ONE.   SOME TRADE
 OR OTHER NAMES: NAPHYRONE.
   (69) ALPHA-PYRROLIDINOBUTIOPHENONE. SOME TRADE OR OTHER NAMES: 2-PBP.
   (70) 1-PENTYL-3-(1-NAPHTHOYL)INDOLE.  SOME  TRADE  OR   OTHER   NAMES:
 JWH-018 AND AM678.
   §  4.  Subdivision  (c)  of  schedule II of section 3306 of the public
 health law is amended by adding a new paragraph 29 to read as follows:
   (29)   THIAFENTANIL   (4-(METHOXYCARBONYL)-4-(N-   PHENMETHOXYACETAMI-
 DO)-1-[2-(thienyl)ethyl]PIPERIDINE).
   § 5. Paragraph 63 of subdivision (h) of schedule II of section 3306 of
 the  public health law is renumbered paragraph 65 and two new paragraphs
 63 and 64 are added to read as follows:
   (63) METHASTERONE (2{ALPHA}17{ALPHA}-DIMETHYL-5{ALPHA}-ANDROSTAN-
 17{BETA}-OL-3-ONE).
   (64) PROSTANOZOL (17{BETA}-HYDROXY-5{ALPHA}-ANDROSTANO{3,2-C}PYRAZOLE).
   § 6. Subdivision (c) of schedule III of section  3306  of  the  public
 health law is amended by adding a new paragraph 15 to read as follows:
   (15) PERAMPANEL.
   §  7.  Subdivision  (c)  of  schedule IV of section 3306 of the public
 health law is amended by adding two new paragraphs 54 and 55 to read  as
 follows:
   (54) ALFAXALONE.
   (55) SUVOREXANT.
   §  8.  Subdivision  (f)  of  schedule IV of section 3306 of the public
 health law, as added by chapter 664 of the laws of 1985, paragraph 2  as
 added  by  chapter  457  of the laws of 2006 and paragraph 3 as added by
 section 14 of part C of chapter 447 of the laws of 2012, is  amended  to
 read as follows:
   (f) Other substances. Unless specifically excepted or unless listed in
 another  schedule,  any material, compound, mixture or preparation which
 contains any quantity of the following substances, including its  salts,
 ISOMERS, AND SALTS, OF SUCH ISOMERS:
   (1) Pentazocine.
   (2) Butorphanol (including its optical isomers).
   (3) Tramadol in any quantities.
   (4) LORCASERIN.
   (5) ELUXADOLINE.
   §  9.  Subdivision  (d)  of  schedule  V of section 3306 of the public
 health law is amended by adding a new paragraph 4 to read as follows:
   (4) BRIVARACETAM.
   § 10. This act shall take effect on the ninetieth day after  it  shall
 have become a law.

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Senate Bill S5357A

Sponsored By

Archive: Last Bill Status - In Senate Committee Health Committee

Jun 13, 2017 - Floor Vote

Floor Vote: Jun 13, 2017

May 23, 2017 - Health Committee Vote

Health Committee Vote: May 23, 2017

Bill Amendments

co-Sponsors

2017-S5357 - Details

2017-S5357 - Summary

2017-S5357 - Sponsor Memo

2017-S5357 - Bill Text download pdf

co-Sponsors

2017-S5357A (ACTIVE) - Details

2017-S5357A (ACTIVE) - Summary

2017-S5357A (ACTIVE) - Sponsor Memo

2017-S5357A (ACTIVE) - Bill Text download pdf

Comments

Senate Bill S5357A

Share this bill

Sponsored By

Archive: Last Bill Status - In Senate Committee Health Committee

Bill Amendments

co-Sponsors

2017-S5357 - Details

2017-S5357 - Summary

2017-S5357 - Sponsor Memo

2017-S5357 - Bill Text download pdf

co-Sponsors

2017-S5357A (ACTIVE) - Details

2017-S5357A (ACTIVE) - Summary

2017-S5357A (ACTIVE) - Sponsor Memo

2017-S5357A (ACTIVE) - Bill Text download pdf

Comments